efficacy of clinical diagnosis of the disease in unselected populations of patients; thirdly, to assess the efficacy of clinical evaluation of treatment with thyroxine; and, lastly, to see whether a single analysis of the serum thyroid stimulating hormone concentration by recent methods would be enough to identify an abnormality of thyroid functioni.
Of the roughly 17400 adults in the study community, 111 women and 10 men were being treated for thyroid disease. Screening detected 68 patients (3.5%) not receiving thyroxine who had a serum thyroid stimulating hormone concentration of mU/l or less, all ofwhom were followed up clinically.
Fifty of these patients were also studied biochemically during foliow up. Only nine ofthe 68 patients had thyroid disease (three with thyrotoxicosis requiring treatment), no evidence of the disease being found in the remainder. Sixteen patients had spontaneous hypothyroidism requiring treatment, and neither these nor three patients with thyrotoxicosis had been detected at the preceding clinical examination. Of 35 patients in whom thyroid disease was suspected clinically at screening, none had laboratory evidence of thyroid dysfunction.
In this series 1-3% of all women in the study community (2-6% of all 50-59 year olds) and 0-1% of the men were being treated for thyroid disease at the primary care centre, roughly 1-0% of adults subjected to screening were found to have thyroid disease requiring treatment, and most patients with a thyroid stimulating hormone concentration of 0-20 mU/l or less did not have thyroid dysfunction. It is concluded that measuring the basal serum thyroid stimulating hormone concentration by present methods is insufficient for the biochemical assessment of thyroid dysfunction in unselected populations.
Introduction
Autoimmune thyroid disease is a common endocrine disorder, predominantly affecting women. Thus the prevalence of treated spontaneous hypothyroidism in the Whickham study was roughly 1 0% among women aged over 18 compared with less than 0-1% in the male population. In the same study the prevalence of hyperthyroidism in women was reportedly about 1-9% (0-16% in men). Some 25-80% of hyperthyroid women may later develop hypothyroidism as a result of subtotal thyroidectomy or various schemes of radioiodine treatment. 2 The prevalence of undiagnosed thyroid dysfunction (hypothyroidism or hyperthyroidism) in the female population has been reported to be 0-3-0-6% and 0-5-0-6%. 3 In Sweden the detection and management ofpatients with thyroid disease is mostly undertaken at primary care level, so forming an important part of the work of primary care centres. We have shown that clinical methods of diagnosing thyroid disease in unselected patient populations at medical outpatient departments have poor sensitivity and specificity.4 This paper examines the prevalence of established and undiagnosed thyroid disease in a primary care centre serving a population representative of that of Sweden as a whole. The study aimed at (a) estimating the total burden of thyroid disease in primary care centres in Sweden, (b) assessing the efficacy of clinical diagnosis of thyroid disease in unselected patient populations, (c) assessing the efficacy of clinical evaluation of thyroxine treatment, and (d) evaluating proposals that single analysis of the serum thyroid stimulating hormone concentration by recent methods would be enough to identify abnormal thyroid function.
Study population and methods
Molnlycke is situated in a predominantly rural area close to Gothenburg on the Swedish west coast. Of the 24800 residents served by the primary care centre, about 17400 are aged 18 30 patients receiving thyroxine supplementation after completion of the screening study and instructed those who returned to take their daily dose after blood sampling.
ASSAYS
Assays of thyroid stimulating hormone and free thyroxine concentrations were usually performed within two days after blood sampling in order to allow an early decision about recalling the patient; other assays were done later. Precision of the assays was assessed with four different types of pooled serumnamely, (a) serum from patients with high free thyroxine concentrations, (b) serum from blood donors (predominantly men), (c) serum from middle aged and early postmenopausal women, and (d) serum from patients with high thyroid stimulating hormone concentrations. In some runs we had to delete single controls because of lack of reagents. As indicated below, changes to a new batch were done during the study for some pools. Controls were included at the beginning and end of each run. Samples used for calibration and from controls and patients were analysed in duplicate.
Serum thyroid stimulating hormone concentration was determined with an immunoenzymometric assay (Abbott Laboratories, north Chicago) with a detection limit of 0 05 mU/l. The "capture" antibodies are two f3 specific monoclonal antibodies bound to a bead, and the "signal" antibody is the Fab fragment of an at specific monoclonal antibody conjugated with horseradish peroxidase. The analysis was carried out according to the manufacturer's instructions, by using manual procedures throughout. Table II shows the within assay precision profile for patients' specimens expressed as the coefficient of variation at different ranges of concentrations. The total between assay coefficient of variation for control samples with a high free thyroxine concentration was 25-8% at the beginning of the assay run and 26-3% at the end (mean concentrations 0-296 and 0-294 mU/l, respectively; No of runs= 132). Coefficients of variation for "euthyroid" pools were 11-6% and 12-3% (mean concentration 1-2 mU/l both at the beginning and at the end) and 8-9% and 8-2% (mean concentrations 1 -91 and 1 92 mUll, respectively; n= 132). For two different pools with a high thyroid stimulating hormone concentration coefficients of variation were 6-8% and 6 1% (mean concentrations 16 4 and 16 4 mU/l; n=74) and 7-6% and 9 0% (mean concentrations 39 7 and 39 4 mU/l; n=83); both control assays were run during a transition period. (15 1 pmolUl) ; for runs with pooled serum from middle aged and early postmenopausal women 6-4% (15-3 pmol/l) and 6 9% (15-3 pmol/l); and for pooled serum containing high thyroid stimulating hormone concentrations 6 2% (9 11 pmolUl) and 7-6% (9 07 pmol/l). Thus, though there was a trend towards lower precision at the end of the run, there was negligible, if any, within assay bias. There was no drift during the study.
Total thyroxine concentration was determined with a single antibody macrogol (polyethylene glycol) radioimmunoassay (thyroxine (25I) radioimmunoassay kit; Farmos Diagnostica, Turku) and free 3,5,3'-triiodothyronine concentration with a 125I labelled analogue radioimmunoassay (Amerlex-M free T3; Amersham International, United Kingdom). Total 3,5,3'-triiodothyronine concentration was determined with a double antibody macrogol radioimmunoassay (T3 RIA double antibody; Diagnostic Products, Los Angeles), in all cases with free thyroxine >21 0 pmol/l. Thyroxine binding globulin was determined by a single antibody macrogol radioimmunoassay (RIA-gnost TBG; Behringwerke AG, Marburg). Serum microsomal antibodies were determined with a '25l-protein A sandwich method (PROMAK) and thyroid stimulating hormone receptor antibodies by a '25I-thyroid stimulating hormone competition method (TRAK; Henning Berlin GmbH, West Berlin). Table IV lists the decision limits used in the study. Details of performance of the assays will be reported separately. In patients with microsomal antibodies and thyroid stimulating hormone concentrations of BMJ VOLUME 297 0 20 mU/l or less we also used an immunofluorescence method (thyroid antibody test system and mitochondrial antibody test system; SciMedX, Denville, New Jersey). Screening for antibodies binding to the thyroxine analogue used in measuring the free thyroxine concentration was performed as described., Further evaluation in these cases and of patients with other abnormal binders was done by electrophoresis in agarose gel after incubation with each of several labelled ligands. ' The protirelin (thyroid stimulating hormone releasing hormone) stimulation test was carried out with the patient semirecumbent. Blood was drawn from an indwelling venous catheter flushed with saline. Heparin was not used. Five specimens were taken at 10 minute intervals. Protirelin 200 [tg (TRH-Roche) was given through the catheter immediately after drawing the second specimen. A positive response was taken as a rise of 0 10 mU/l or more in the last two specimens compared with the first two, the maximal thyroid stimulating hormone response being calculated as the maximal difference in relation to the specimen taken immediately before protirelin.
Results

CROSS SECTIONAL STUDY
Altogether 111 women and I0 men-that is, 1 3% of all women in the study community and 0 1% of the men-were being treated for thyroid disease at the primary care centre. The largest proportion at any age (2 6%) was among women aged 50-59 (table I) .
PERFORMANCE OF THYROID STIMULATING HORMONE ASSAY
The within assay coefficient of variation for the immunoenzymometric thyroid stimulating hormone assay was calculated from the differences between duplicate analyses of all samples (screening plus recall). Table II gives the results for thyroid stimulating hormone concentrations ranging from 0-05 to 100 mU/l. As expected, imprecision was high (coefficient of variation >9-9%) at low thyroid stimulating hormone concentrations (<07 mU/l), whereas coefficients of variation of around 5% or less were generally recorded at thyroid stimulating hormone concentrations of >2 0 mU/l. 
PATIENTS RECEIVING THYROXINE
In the cross sectional study we found 98 patients being treated with thyroxine, the main indications being spontaneous hypothyroidism (n=52) and hypothyroidism occurring after thyrotoxicosis (n=21). (15) years. Forty six patients receiving thyroxine were also being treated for other diseases, the most common being cardiac decompensation (n= 14) , diabetes mellitus (n=7), arterial hypertension (n= 7), obstructive pulmonary disease (n= 5), rheumatoid arthritis (n=3), and pernicious anaemia (n = 2). Nine patients receiving thyroxine attended the centre more than one a year for their thyroid disease.
Seventy one of the 2000 patients subjected to screening were receiving thyroxine. Of these, only 25 had serum thyroid stimulating hormone concentrations of 0 20-4-0 mU/l. Low concentrations (Z0 20 mU/1) were found in 39 patients and high concentrations (>4 0 mU/l) in seven. One patient had a thyroid stimulating hormone concentration of 71 mU/l but was clinically euthyroid. Raised serum free thyroxine concentration (>21-0 pmol/l) was found in 39 patients, 11 having values of ¢v30-0 pmol/l. A single patient had a raised serum triiodothyronine concentration (3 1 nmol/l) indicating autonomous thyroid function9" (verified by scintigraphy). In this BMJ VOLUME 297 17 DECEMBER 1988patient serum thyroid stimulating hormone was undetectable, the free thyroxine concentration was 48 pmol/l, and the free triiodothyronine concentration was 14 pmol/l. She also was classified as euthyroid. Thus a pronounced biochemical abnormality was found in two of the 71 patients, and both were classified as euthyroid. Of 30 patients receiving thyroxine who were recalled, 28 returned and had their blood sampled before their daily dose of the drug. In 16 cases the serum thyroid stimulating hormone concentration was between 0 20 and 4 0 mU/l, and in 12 cases the concentration was s-020 mU/l. Seven patients had a serum free thyroxine concentration 2 10 pmol/l, but in none did the value exceed 30 pmol/l.
Discussion
All primary care in Molnlycke is provided by the primary care centre, and no private doctors practise in the area. There is an affiliated 600 bed county hospital, to which patients with severe hyperthyroidism and hypothyroidism are admitted as well as patients for thyroid surgery. Most of these patients, however, are seen initially at the primary care centre and return to the centre once treatment in hospital is completed (see table V ). In accordance with government policy in Sweden increasing numbers of patients with thyroid disease have been managed in primary care centres over the past few years.
In this series biochemical screening detected 21 patients with previously undiagnosed thyroid disease needing treatment or surveillance. They represented virtually 1% of the patients screened, which agreed with our findings in a survey among short stay hospital medical patients and outpatients. 4 The patients, mostly women, were attending the centre either for acute conditions or for routine care of non-thyroid disease and in no case were there symptoms that we could attribute to thyroid disease. In patients with only slightly raised serum thyroid stimulating hormone concentrations, thyroid hormone concentrations within reference limits, and no obvious signs or symptoms suggesting hypothyroidism it is not possible to verify a diagnosis of thyroid dysfunction until after at least six months of treatment," and this was so in the study. As further evidence of the difficulty of diagnosing thyroid dysfunction clinically, in none of 35 patients in whom the disease was suspected clinically did biochemical evaluation confirm the diagnosis.
Ninety eight patients were receiving thyroxine supplementation at the centre, in half of them this being their only reason for contact with the centre. These patients had a mean age of 56 years and had begun thyroxine supplementation at a mean age of 42. In Sweden the average life expectancy at the age of 56 is roughly 24 years (21 years for men, 26 years for women), so that these patients may be expected to be needing management by the centre for many years.
Though the efficacy of thyroxine treatment is usually evaluated clinically, our finding patients with hitherto unrecognised thyroid autonomy as well as a patient with a high thyroid stimulating hormone concentration indicating poor therapeutic compliance underlines the value of biochemical testing. Nevertheless, it is important to tell the patient to take his or her daily dose of thyroxine after blood sampling. This is illustrated by our finding a high free thyroxine concentration (¢r21 pmolIl) in over half the patients whose blood was sampled without reference to the time of dosing as compared with only a quarter of patients given proper instructions. We also cannot exclude the possibility that temporary inhibition of conversion of thyroxine to triiodothyronine due to non-thyroidal illness may have been a factor in the high free thyroxine concentrations noted in some patients receiving thyroxine. Hence results of biochemical determinations in a patient taking thyroxine might also be misleading if the sample has been taken without consideration of the general state of health.
This study highlights the importance of a rational choice of a low decision limit for serum thyroid stimulating hormone concentration when using the new generation of thyroid stimulating hormone assays in general clinical practice-that is, outside specialised thyroid clinics. Judged from information available on the present assay at the start of the study a value of 0 40 mU/l seemed appropriate. It soon became apparent that if we used this limit an unduly large number of patients would have to be recalled. The possibility that performance of the assay might cause a negative bias of thyroid stimulating hormone values was ruled out in separate experiments with controls and diluted reference preparations supplied by the manufacturer. Our results showed that reference limits for euthyroid people obtained by conventional procedures -that is, by selecting apparently healthy subjects-were inappropriate as a basis for defining decision levels for thyroid stimluating hormone assays in clinical practice, as a large proportion of our patients with only minor non-thyroidal illness had lower thyroid stimulating hormone concentrations than those reported for euthyroid people. Our low limit of 0-20 mU/l was selected from, among other things, considerations of the imprecision of the assay. Though precision was poor at low thyroid stimulating hormone concentrations, it compared favourably with that of other presently available assays,'2 13 and with this limit there was little risk that hyperthyroid patients would go undetected provided that they did not have heterophilic antibodies interfering with the assay. '4 In only one of our 2000 patients did we find a spurious rise (5 mU/l) in a euthyroid patient with a thyroid stimulating hormone concentration of about 1 mU/l, determined with two immunoradiometric assays and one radioimmunoassay.
Our finding five patients with repeatedly undetectable basal thyroid stimulating hormone concentrations who had a clear thyroid stimulating hormone response to protirelin agrees with the results of Spencer et al in thyroxine treated patients.'5 Spencer et al concluded that present generally available thyroid stimulating hormone assays cannot safely exclude the presence of significant thyroid stimulation by thyroid stimulating hormone despite the low detection limits. Thus suppressed thyroid stimulating hormone secretion in a single patient cannot be diagnosed at present from basal measurements alone, though in mixed patient populations there is a correlation between basal and protirelin stimulated thyroid stimulating hormone secretion. 6 Reports on detection limits of the "new generation" thyroid stimulating hormone assays have paid little attention to assay performance at low thyroid stimulating hormone concentrations, either analytically or clinically."'7'9 For instance, judging from the precision profile in a recent report of a mulicentre study on 10 such methods only one had a within assay coefficient of variation of less than 10% at thyroid stimulating hormone concentrations of up to 0 70 mU/1.'3 Imprecision with solutions used for calibration or with commercially available controls may be different from that with patients' specimens, so it is unfortunate that published information is often poor in this respect. In the face of the low clinical specificity of low thyroid stimulating hormone concentrations measured by current methods we must resort to determining circulating thyroid hormone concentrations for evaluating the clinical relevance of a low thyroid stimulating hormone concentration; also the sensitivity of immunometric assays to heterophilic antibodies calls for the availability of thyroid hormone measurements when finding a normal or raised thyroid stimulating hormone concentration in cases of suspected hyperthyroidism. A notable achievement with recent assays (to our knowledge not discussed previously) is the increased analytical specificity at the upper end of the distribution-say, the 3-6 mU/l range-at which these assays, in conjunction with modern ligand assays of microsomal antibodies, permit a more reliable diagnosis of autoimmune thyroid disease of potential clinical importance versus adaptive increase in thyroid stimulating hormone secretion after disease (findings to be published).
This study also highlights the problems associated with interpreting the results of the protirelin stimulation test. Before the introduction of the new generation of thyroid stimulating hormone assays an incremental rise in serum thyroid stimulating hormone of 1-0-2 0 mU/l after an injection of protirelin was often used as the detection limit. In 
MULTICULTURAL MEDICINE
Beware of dried fruit inflation Bulk purgatives contain plant fibre such as bran, ispaghula, or sterculia. Synthetic agents such as methylcellulose can also keep colonic contents on the move. They absorb water, thereby increasing the volume of the stools and so softening the faeces. Adequate hydration is advised when taking such tablets or granules.
Constipation is common in Western societies because of low fibre diets, and it is such a terrible thing that it is written all over the face of the chronic sufferer. A consultant geriatrician often teaches the house officer and night nurse that "if you keep the patient's bowels open he will keep his mouth shut." Being "bunged up" is such an uncomfortable feeling that people will resort to anything-drugs, herbs, and health foods-and they often eat dried figs and apricots. Beware, there is a danger.
Wu and Copeland have reported that a 61 year old woman presented with an obstruction of the small intestine, and through a proximal ileostomy a 3 cm wide, fresh looking apricot was removed.' She insisted that she had never swallowed such a fruit, but her daughter had presented her with a packet of dried apricots three days before her illness. The authors said that a dried apricot soaked in water for 24 hours will swell to the size of a fresh apricot and retailers of dried fruit should display a health warning: "Not to be swallowed whole or it may turn into a jam."
Moslems eat dried dates (chohara) as a religious delicacy. A dried date is the substitute for a fig or an apricot. It is customary to break the daily fast in the month of Ramadan with fresh or dried dates. At a marriage
Interesting misunderstandings
Canadian notepaper Like Australians, Canadians are well known for their love of the British monarchy, and a Canadian doctor will hardly ever miss the chance to present a paper at a meeting in Britain organised by a royal college if invited. On one occasion an English royal college organised a three day international conference: a keynote speaker was chosen from the World Health Organisation; 18 main speakers for six sessions were chosen from various countries; as a side show, 36 free standing papers were planned, to be presented in a room adjacent to the main conference hall; and 50 posters on different medical topics were planned for display in the corridors. The speakers and poster authors were invited from all over the world to send abstracts for consideration.
A Canadian doctor wrote his forwarding letter on the notepaper of a Canadian national college and sent an abstract for a freestanding paper. This caused confusion because if he was to represent a national college, according to the policy of the organising committee, his paper should be accepted and the house staff would help him to bring it up to the required standard if necessary. But if he was speaking for himself then his abstract had to be judged on open merit. The president of the English college rang the president of the Canadian national college to inquire if the doctor was representing that college. The Canadian president denied any college connection with the doctor, except that he was an ordinary member, and was annoyed with the Canadian doctor. Both presidents thought he was trying to pull the wool over their eyes. The organising committee were up ceremony, during a pilgrimage to Mecca (Hadj), and to celebrate the anniversary of the death of a holy man dates are distributed among all the guests. Elderly Moslems feel spiritually attached to this holy fruit which causes such physical relief. No wonder they look happy.
Moslems returning from Hadj often bring dried dates as presents for relatives, friends, and the doctor, even if he or she is a European. It is true that the Moslem faith has generated a world. It is estimated that in 1950 every seventh human being was a Moslem and in 1985 every fifth human being followed Islam or bore its name.2 It is the second largest religion in Britain and Russia, and the third largest faith in the United States. There are about two million Moslems in Britain (and 515 mosques with attached schools). They immigrated from Arabian, Asian, and south east Asian countries.
A hakim (Moslem herbalist) always considers "dried dates" in the differential diagnosis of acute abdomen but does not ask about figs. In these days of increasing transcultural contact it is essential that a European doctor asks about dried dates and an Eastern physician should not forget to ask about dried apricots. People are using more health foods than ever before and every doctor must bear in mind dried fruits as a possible cause of intestinal obstruction. in arms, and his paper was nearly rejected on ethical grounds. Fortunately, a committee member spotted the cultural misunderstanding between Britain and the Commonwealth, and the paper was rejudged.
In Britain members of a royal college do not use its notepaper. This is used exclusively by its officers, and no rubber stamp is necessary, whereas it is customary in almost all the Commonwealth countries for members to use the college notepaper, as they would wear a college tie, scarf, or cufflinks, and a letter is considered official only if an officer of the college puts a rubber stamp under his or her signature.
Eastern visiting card
The Royal Society of Medicine is a prestigious institution in the United Kingdom. Wednesday 2 July 1986 was a royal occasion and Her Majesty the Queen opened the society's new building. Many members attended the event, and some exchanged visiting cards with each other. An English member showed the visiting card from an Egyptian member to an Asian colleague, pointing out that it bore the curriculum vitae of the Egyptian doctor! The westernised Asian laughed and told him of a difference in thinking. In the West a doctor's visiting card simply bears his or her name and address, and it is a courtesy to exchange cards but customary not to follow this up. In Eastern cultures, however, a doctor's visiting card bears not only all his diplomas but also important past appointments, and worse still, he may try to call. You have been warned. -BASHIR QURESHI, general practitioner, Hounslow, London
